PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

CJC-1295 Without DAC

Price range: £89.99 through £134.99

Buy CJC-1295 Without DAC Peptide in UAE – In Stock & Ready to Ship

CJC-1295 Without DAC is a widely researched peptide known for its role in growth hormone releasing and hypothalamic signalling studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.

For research use only. Not intended for human or veterinary use.

You may also like…

Product Description

CJC-1295 Without DAC UAE | Buy Research-Grade GHRH Peptide | ≥99% Purity

CJC-1295 Without DAC is the most widely studied synthetic GHRH analogue available to researchers in the UAE — a modified 29-amino acid peptide that stimulates pulsatile growth hormone release through GHRH receptors, offering improved enzymatic stability over native GHRH while preserving the natural, episodic GH secretion pattern that makes it the preferred GHRH analogue for physiological GH axis research. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade CJC-1295 Without DAC with fast international dispatch and full batch documentation included.

✅ ≥99% Purity — HPLC & Mass Spectrometry Verified

✅ Batch-Specific Certificate of Analysis (CoA)

✅ Sterile Lyophilised Powder | GMP Manufactured

✅ Fast International Dispatch to UAE & GCC

What is CJC-1295 Without DAC?

CJC-1295 Without DAC — also known as Modified GRF(1-29) or Mod GRF 1-29 — is a synthetic analogue of the first 29 amino acids of Growth Hormone-Releasing Hormone (GHRH), with four specific amino acid substitutions that significantly improve its stability against enzymatic degradation compared to native GHRH and Sermorelin.

The “Without DAC” distinction is important. It separates this compound from CJC-1295 With DAC, which carries a Drug Affinity Complex enabling albumin binding and extending half-life to approximately 7–8 days. Without DAC, the half-life sits at around 30 minutes — substantially longer than native GHRH (~7 minutes), but short enough to produce pulsatile GH release that closely mirrors the body’s natural secretion rhythm. This makes it the preferred GHRH analogue for research examining physiological GH axis dynamics rather than sustained GH elevation.

What Does CJC-1295 Without DAC Do?

In laboratory research, CJC-1295 Without DAC acts exclusively through GHRH receptors (GHRHR) on pituitary somatotroph cells, stimulating GH gene expression and pulsatile GH secretion via the cAMP signalling pathway. Research applications include:

  • GHRH receptor pharmacology and binding studies
  • Pulsatile GH secretion dynamics and pulse frequency/amplitude analysis
  • Hypothalamic-pituitary axis regulation studies
  • Structure-activity relationship (SAR) investigations on GHRH analogues
  • Dual-pathway GH stimulation protocols when combined with GHSR-1a agonists such as Ipamorelin

Its improved stability over native GHRH makes it a more consistent and practical research tool across multi-timepoint experimental protocols. All applications are for research use only.

What Do Studies Say About CJC-1295 Without DAC?

CJC-1295 Without DAC has one of the most well-characterised research profiles among synthetic GHRH analogues. Studies have confirmed that the four amino acid substitutions in its sequence meaningfully extend functional half-life while maintaining full GHRHR binding activity and pulsatile GH release — addressing the primary limitation of native GHRH as a research tool without introducing the sustained GH elevation profile of the DAC form.

Research examining the compound’s receptor pharmacology has validated its selective engagement of GHRHR on pituitary somatotrophs, with GH secretion responses consistent across controlled pre-clinical models. Studies combining CJC-1295 Without DAC with GHSR-1a agonists have documented a synergistic GH release response — greater than either compound alone — reflecting the natural co-regulatory interaction between the GHRH and ghrelin receptor pathways at the pituitary level. This combination has become one of the most referenced dual-pathway GH secretion protocols in endocrinology research.

CJC-1295 Without DAC vs Related GHRH Analogues

Compound Half-Life GH Pattern Stability vs GHRH Research Profile
CJC-1295 Without DAC ~30 min Pulsatile High Most studied
CJC-1295 With DAC ~7–8 days Sustained Very High Well-documented
Sermorelin ~10–20 min Pulsatile Moderate Well-documented
Native GHRH ~7 min Pulsatile Baseline Reference compound
Tesamorelin ~25 min Pulsatile High Growing

Product Specifications

Parameter Detail
Type GHRH Analogue
Receptor Target GHRHR (pituitary somatotrophs)
Sequence Length 29 AA (modified)
Half-Life ~30 minutes
Purity ≥99%
Verification HPLC & Mass Spectrometry
Form Lyophilised Powder
Solubility Sterile or bacteriostatic water
Storage -20°C, protected from light
Intended Use Research use only

Buying CJC-1295 Without DAC in UAE — What’s Included

Every order dispatched to the UAE and GCC includes:

  • Batch-specific Certificate of Analysis (CoA)
  • HPLC Chromatogram
  • Mass Spectrometry Confirmation
  • Sterility & Endotoxin Testing Reports
  • Reconstitution Protocol
  • Technical Research Support

Frequently Asked Questions — CJC-1295 Without DAC UAE

Can I buy CJC-1295 Without DAC in the UAE?

Yes. We supply research-grade CJC-1295 Without DAC with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. These compounds are supplied strictly for laboratory research use only.

What is the difference between CJC-1295 Without DAC and With DAC?

The DAC modification enables albumin binding, extending half-life to ~7–8 days and producing sustained GH elevation. Without DAC, the half-life is ~30 minutes, producing pulsatile GH release that more closely mirrors natural GH secretion. Research requiring physiological GH dynamics typically uses the Without DAC form; research requiring prolonged GH axis stimulation uses the With DAC form.

Why is CJC-1295 Without DAC commonly paired with Ipamorelin in research?

The two compounds act through entirely different receptor systems — CJC-1295 Without DAC via GHRHR and Ipamorelin via GHSR-1a (ghrelin receptor). Co-activation of both pathways produces a synergistic GH secretion response that exceeds either compound alone, reflecting the natural dual-pathway regulation of pituitary GH release. This combination is the most widely studied dual-pathway GH secretion protocol in current endocrinology research.

How is CJC-1295 Without DAC reconstituted for laboratory use?

Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. Reconstitute to your research protocol’s required concentration. Aliquot and store at -80°C for longer-term use to minimise freeze-thaw degradation.

How quickly is this delivered to UAE?

Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.

Research Disclaimer

CJC-1295 Without DAC is supplied exclusively for legitimate scientific research conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic or veterinary application. It must be handled solely by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. By purchasing, you confirm this compound will be used exclusively for approved in vitro or pre-clinical research purposes.

Receive News

Subscribe for the Updates!